BTMD vs VRTX · P/E 5.3, rev $89.2M vs P/E 30, rev $3.33B
biote Corp (BTMD) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
biote Corp (BTMD) is a medical care facilities company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported BTMD revenue for 2026-06-30 was $89.2M. Net income was -$4.3M. Revenue was up 98.4% from 2026-03-31 to 2026-06-30. BTMD currently screens at market cap $80.7M and trailing P/E 5.3.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
BTMD currently screens at market cap $80.7M and trailing P/E 5.3. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the BTMD and VRTX stock pages for the full models.
Not investment advice.